Genetic Test Hailed As Tool for Brain Cancer ; Screening Tells Who Drug Will Benefit

Summary

---

LONDON - A simple genetic test can identify which patients with deadly brain tumors will be helped by a treatment hailed as the first significant advance against the disease in decades, scientists said Wednesday.

A study by Swiss doctors, presented Wednesday at a conference in Geneva, found 46 percent of patients with the right genetic profile were alive after two years if they got the drug, temozolomide, as well as radiotherapy. The chance of survival among patients with the wrong genetic signature was only 14 percent not much better than with radiotherapy alone.

See the full content of this document

Extract

---

Genetic Test Hailed As Tool for Brain Cancer ; Screening Tells Who Drug Will Benefit

Experts say the test could avoid raising false hopes in those patients w...

See the full content of this document

---